Astrazeneca AZN
NYSE AZN
$164.56 -0.37 (-0.22%)
At close: Aug 20, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Net Margin (2009 - 2026)

Astrazeneca (AZN) posted quarterly Net Margin of 16.3% for Q2 2026, down 65.0% year-over-year from 46.56% in Q2 2025, and down 99.59% quarter-over-quarter from 4000.0% in Q1 2026.

Astrazeneca (AZN) Net Margin (2009 - 2026) Analysis & Trends

Astrazeneca's Net Margin history runs 18 years deep, the most recent figure standing at 16.3% for Q2 2026.

  • In Q2 2026, Net Margin fell 65.0% year-over-year to 16.3%; the TTM figure through Jun 2026 stood at 70.63% (up 168.0% YoY), while the FY2025 annual figure was 17.41%, up 440.0% from the prior year.
  • Net Margin for Q2 2026 stood at 16.3%, down from 4000.0% in the prior quarter.
  • The five-year high for Net Margin was 48250.0% in Q2 2024, with the low at 12400.0% in Q2 2022.
  • The 5-year median for Net Margin is 1250.02% (2023), against an average of 7642.88%.
  • The sharpest annual moves came in 2024 and 2025: Net Margin jumped 4730803 bps in 2024, then tumbled 4823305 bps in 2025.
  • Astrazeneca's Net Margin stood at 1083.54% in 2022, then sank by 48 bps to 561.83% in 2023, then tumbled by 67 bps to 184.05% in 2024, then jumped by 24984 bps to 46166.67% in 2025, then plunged by 100 bps to 16.3% in 2026.
  • Business Quant data shows AZN's Net Margin at 16.3% in Q2 2026, 4000.0% in Q1 2026, and 46166.67% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 21.86%
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 21.28%
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn -8.05%
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 22.65%
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 16.30%
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 23.62%
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -134.51%
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -1.58%
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 5.17%
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 2.96%

Historic Data

Download Data
DateValue
Jun 30, 2026 16.30%
Mar 31, 2026 4,000.00%
Dec 31, 2025 46,166.67%
Sep 30, 2025 23,409.09%
Jun 30, 2025 16.95%
Mar 31, 2025 5,428.38%
Dec 31, 2024 184.05%
Sep 30, 2024 4,498.31%
Jun 30, 2024 48,250.00%
Mar 31, 2024 4,842.22%
Dec 31, 2023 561.83%
Sep 30, 2023 1,416.49%
Jun 30, 2023 941.97%
Mar 31, 2023 8,077.78%
Dec 31, 2022 1,083.54%
Sep 30, 2022 921.35%
Jun 30, 2022 -12,400.00%
Mar 31, 2022 156.98%
Dec 31, 2021 -145.61%
Sep 30, 2021 -1,585.60%